Featured Articles
Latest Articles

Article
What Skills Do the Next Generation of Scientists Need?
Nine scientists from academia and industry offer their take on the crucial skills tomorrow’s scientists will need to thrive in an evolving research landscape, from AI to digital lab fluency.

Article
Building a More Inclusive Future in Biotech
Technology Networks recently had the pleasure of interviewing Dr. Tyler Brown, founder, president and chair of OUTbio San Diego, to learn more about the organization’s origins, rapid growth and mission to create lasting impact.

Article
Host Cell Protein Analysis in Biologics Manufacturing
The article explores the importance of host cell protein analysis in biologics manufacturing, detailing challenges in detection, evolving analytical methods and increasing regulatory expectations.

Article
European Pharma Experts React to US Tariff Uncertainty
Learn more about the effects US pharmaceutical tariffs could have on European companies and their strategies for overcoming cost and supply chain challenges.

Article
Transforming Healthcare: What’s on the Horizon for Cell Therapies?
This article explores the current landscape and future potential of cell therapies, including CAR T-cell and stem cell-based approaches, highlighting their expanding clinical use, underlying mechanisms and the challenges that lie ahead.

Article
Modeling Tauopathy: How New Mouse Models Could Help Map Alzheimer’s Disease
While amyloid-beta has been a central focus in drug development, increasing evidence points to tau pathology as a more accurate predictor of disease progression. This is where the work of Dr. Naoto Watamura could be vital.

Article
Novel Cystic Fibrosis Treatments Breathe New Life Into the Therapeutic Space
Discover the latest in cystic fibrosis treatment, from CFTR modulators to ENaC blockers and emerging inhalable gene therapies.

Article
Building the Future of Cell Therapies: Insights From Dr. Andrew Mancini
Presenting at Technology Networks’ Cell and Gene Therapy 2025 Symposium, Dr. Andrew Mancini, senior corporate development manager at MaxCyte, shared his insights on how engineered cell therapies have evolved over the past eight years.

Article
Building Living Therapeutics With Synthetic Biology
This article explores how synthetic biology is revolutionizing therapeutics through engineered cells, precision genetic circuits and AI-driven design, with applications in cancer treatment, vaccine development and next-generation immunotherapies.

Article
How Can Viruses Be Harnessed for Good?
Traditionally, viruses have been thought of as a burden that cause disease. Now, viruses are being harnessed to tackle diseases that medicines can’t, helping fight cancer, genetic disorders and even infectious diseases.
Advertisement